The immunosuppressive PD-1/PD-L1 pathway participates in cancer immune escape via the abnormal activation of the tumor-intrinsic STAT3-PI3K/AKT pathway leading to high expression of PD-L1 resulting in attenuation of anti-tumor T cell responses. This evidence concerns the gene AKT1 and neoplasm.